Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC13H9Cl2NO3S |
InChIKeyTXHQSKPOVJIXCS-UHFFFAOYSA-N |
CAS Registry477844-46-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 Feb 2003 |